The purpose of the foundation is initially to create a Swiss registry that collects treatment and disease data from patients with myeloproliferative neoplasias (MPN). This enables the analysis of the data and the development of new therapies.

​

We are pleased to announced that we have started the collection of MPN patients for our registry. In 2022, the data of 50 patients was already collected and we will continue adding further data in the beginning of 2023. Quarterly, we will inform you about the progress!